Browsing by Author "Uysal, Mukremin"
Now showing items 1-11 of 11
-
Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
Demirci, Umut; Oflazoglu, Utku; Kodaz, Hilmi; Ciltas, Aydin; Kefeli, Umut; Akyol, Murat; Ozturk, Banu; Geredell, Caglayan; Seker, Mehmet Metin; Clhan, Saner; Tastekin, Dldem; Sevinc, Alper; Akinci, Muhammad Bulent; Uysal, Mukremin; Taskoylu, Burcu Yapar; Duran, Ayse Ocak; Yazici, Omer Komi; Karaoglu, Aziz; Benekli, Mustafa; Buyukberber, Suleyman (AMER SOC CLINICAL ONCOLOGY, 2014)… -
Clinicopathological Characteristics and Prognosis of Patients According To Recurrence Time After Radical Nephrectomy for Localized Renal Cell Carcinoma: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO)
Bozkurt, Oktay; Inanc, Mevlude; Hacibekiroglu, Ilhan; Esbah, Onur; Seker, Metin; Ulas, Arife; Aydin, Kubra; Uysal, Mukremin; Kucukoner, Mehmet; Uncu, Dogan; Ciltas, Aydin; Unal, Olcun Umit; Durnali, Ayse; Demirci, Umut; Berk, Veli; Tonyali, Onder; Oksuzoglu, Berna; Karaca, Halit; Ozkan, Metin (INT INST ANTICANCER RESEARCH, 2014)Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years or more than 5 years after nephrectomy and determined predictors of survival and response treatment after recurrence. ... -
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ozaslan, Ersin; Karaca, Halit; Koca, Sinan; Sevinc, Alper; Hacioglu, Bekir; Ozkan, Metin; Ozcelik, Melike; Duran, Ayse O.; Hacibekiroglu, Ilhan; Yildiz, Yasar; Tanriverdi, Ozgur; Menekse, Serkan; Aksoy, Asude; Bozkurt, Oktay; Urvay, Semiha; Uysal, Mukremin; Demir, Hacer; Ciltas, Aydin; Dane, Faysal (LIPPINCOTT WILLIAMS & WILKINS, 2017)The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and to determine the patient group in which these treatments were ... -
The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO
Yazici, Ozan; Ozdemir, Nuriye; Duran, Ayse Ocak; Menekse, Serkan; Ali, Mehmet; Sendur, Nahit; Karaca, Halit; Goksel, Gamze; Arpaci, Erkan; Hacibekiroglu, Ilhan; Bilgetekin, Irem; Kacan, Turgut; Ozkan, Metin; Aksoy, Sercan; Aksoy, Asude; Cokmert, Suna; Uysal, Mukremin; Elkiran, Emin Tamer; Cicin, Irfan; Buyukberber, Suleyman; Zengin, Nurullah (FUTURE MEDICINE LTD, 2016)Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ... -
Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
Turan, Nedim; Benekli, Mustafa; Unal, Olcun Umit; Unek, Ilkay Tugba; Tastekin, Didem; Dane, Faysal; Algin, Efnan; Ulger, Sukran; Eren, Tulay; Topcu, Turkan Ozturk; Turkmen, Esma; Babacan, Nalan Akgul; Tufan, Gulnihal; Urakci, Zuhat; Ustaalioglu, Basak Oven; Uysal, Ozlem Sonmez; Ercelep, Ozlem Balvan; Taskoylu, Burcu Yapar; Aksoy, Asude; Canhoroz, Mustafa; Demirci, Umut; Dogan, Erkan; Berk, Veli; Balakan, Ozan; Ekinci, Ahmet Siyar; Uysal, Mukremin; Petekkaya, Ibrahim; Ozturk, Selcuk Cemil; Tonyali, Onder; Cetin, Bulent; Aldemir, Mehmet Naci; Helvaci, Kaan; Ozdemir, Nuriye; Oztop, Ilhan; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman (AME PUBL CO, 2015)Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed ... -
Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz, Fatih; Buyuksimsek, Mahmut; Sakalar, Teoman; Aydin, Ovgu; Turna, Hande; Babacan, Nalan Akgul; Yildiz, Birol; Arslan, Cagatay; Ozdemir, Nuriye; Urun, Yuksel; Uysal, Mukremin; Gumusay, Ozge; Tufan, Gulnihal; Aslan, Ferit; Paydas, Semra; Demirci, Umut (AMER SOC CLINICAL ONCOLOGY, 2018)… -
Multicenter experience of adult medulloblastoma: A study of Anatolian Society of Medical Oncology (ASMO)
Esbah, Onur; Demirci, Umut; Dane, Faysal; Gunaydsin, Yusuf; Ozdemir, Nuriye; Ekinci, Ahmet Siyar; Kodaz, Hilmi; Yazilitas, Dogan; Rzayev, Rashad; Guney, Yildiz; Seker, Metin; Uysal, Mukremin; Inal, Ali; Bilici, Ahmet; Benekli, Mustafa; Oksuzoglu, Berna; Buyukberber, Suleyman (ZERBINIS MEDICAL PUBL, 2016)Purpose: Medulloblastoma (MB) is rarely seen in adults. For adjuvant therapy in adults the same therapy protocols used in pediatric cases are used. The present study retrospectively evaluated the data of MB patients who ... -
Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder
Erdem, Gokmen U.; Dogan, Mutlu; Sakin, Abdullah; Oruc, Zeynep; Yaman, Emel; Cinkir, Havva Yesil; Uysal, Mukremin; Bozkurt, Oktay; Ozturk, Banu; Aytekin, Aydin; Ozcelik, Melike; Bahceci, Aykut; Cakiroglu, Umut; Turhal, Serdar; Sahin, Suleyman; Uncu, Dogan; Zengin, Nurullah (KARGER, 2018)Objectives: The clinicopathological characteristics, treatment modalities, and effects on the prognosis of pure squamous cell carcinoma (SqCC) and adenocarcinoma (AC) were evaluated. Materials and Methods: 86 patients with ... -
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal, Ali; Kodaz, Hilmi; Odabas, Hatice; Duran, Ayse Ocak; Seker, Mehmet Metin; Inanc, Mevlide; Elkiran, Emin Tamer; Gunaydin, Yusuf; Menekse, Serkan; Topcu, Turkan Ozturk; Urakci, Zuhat; Tastekin, Didem; Bilici, Mehmet; Cihan, Sener; Geredeli, Caglayan; Sezer, Emel; Uncu, Dogan; Arpaci, Erkan; Ozturk, Banu; Bal, Oznur; Uysal, Mukremin; Tanriverdi, Ozgur; Gumus, Mahmut; Ustaalioglu, Bala Basak Oven; Suner, Ali; Cokmert, Suna; Hacibekiroglu, Ilhan; Aydin, Kubra; Isikdogan, Abdurrahman (MEDKNOW PUBLICATIONS & MEDIA PVT LTD, 2018)Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ... -
What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
Kaplan, Muhammet Ali; Urakci, Zuhat; Gumus, Mahmut; Arslan, Ulku Yalcintas; Geredeli, Caglayan; Ozdemir, Nuriye; Koca, Dogan; Oruc, Zeynep; Uysal, Mukremin; Dane, Faysal; Sevinc, Alper; Seker, Mehmet Metin; Aksoy, Asude; Kucukoner, Mehmet; Pilanci, Kezban Nur; Topcu, Turkan Ozturk; Karaagac, Mustafa; Yildiz, Ramazan; Isikdogan, Abdurrahman (AMER SOC CLINICAL ONCOLOGY, 2015)… -
XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
Duran, Ayse Ocak; Karaca, Halit; Besiroglu, Mehmet; Bayoglu, Ibrahim Vedat; Menekse, Serkan; Yapici, Heves Surmeli; Yazilitas, Dogan; Bahceci, Aykut; Uysal, Mukremin; Sevinc, Alper; Hacibekiroglu, Ilhan; Aksoy, Asude; Tanriverdi, Ozgur; Arpaci, Erkan; Inanc, Mevlude; Dane, Faysal; Ozkan, Metin (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this study was to compare ...